Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of medicines for the treatment of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. The Company’s product candidate includes apitegromab, an inhibitor of the activation of latent myostatin for the treatment of spinal muscular atrophy (SMA) and is in the treatment of other myostatin-related disorders. Its product candidate also includes SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 (TGFb1) for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies. The Company is advancing multiple antibody profiles toward product candidate selection, including antibodies that selectively inhibit the activation of latent TGFb1 in the context of fibrotic extracellular matrix and that avoid perturbing TGFb1 presented by cells of the immune system.

SCHOLAR ROCK HOLDING CORP

Spinning Eagle Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not commenced any business operations. The Company has not generated any revenue. 

SOARING EAGLE ACQU - CL A

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It develops therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It commercializes three products, such as EXONDYS 51 (eteplirsen) Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53) and AMONDYS 45 (casimersen) Injection (AMONDYS 45). These commercial products are indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51, exon 53 and exon 45 skipping. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.

Sarepta Therapeutics, Inc.

Invivyd, Inc. is a biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases. It delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify antibodies with a barrier to viral escape. It has a robust pipeline of antibody candidates for the prevention and treatment of COVID-19, including VYD222, a novel antibody. VYD222 is a monoclonal antibody candidate that has demonstrated in vitro neutralizing activity against dominant variants of concern, including XBB.1.5. VYD222 was engineered from adintrevimab (ADG20), which provided neutralizing protection against SARS-CoV-2 for all variants of concern until the emergence of the Omicron BA.2 strain and its sublineages.

INVIVYD INC

InvenTrust Properties Corp. is a multi-tenant retail real estate investment trust (REIT) that is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The Company owns, leases, redevelops, acquires, and manages grocery-anchored neighborhood and community centers, as well as power centers that often have a grocery component. It owns or had an interest in approximately 62 retail properties with a total gross leasable area (GLA) of approximately 10.3 million square feet, which includes four retail properties with a GLA of approximately 1.1 million square feet. The Company focuses on Sun Belt grocery-anchored neighborhoods and community centers. The Company’s subsidiaries include A-S 66 Beltway 8-Blackhawk, L.P., IA Arlington Riverview GP, L.L.C., IA Arlington Riverview Limited Partnership, IA Arlington Riverview LP, L.L.C., IA Atlanta Buckhead Member, L.L.C., IA Atlanta Buckhead, L.L.C., and IA Austin Scofield GP, L.L.C.

INVENTRUST PROPERTIES CORP

iShares Core S&P 500 ETF (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Standard & Poor’s 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market. The component stocks are weighted according to the total float-adjusted market value of their outstanding shares. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund invests in sectors, such as consumer non-cyclical, financial, energy, technology, communications, industrial, consumer cyclical, basic materials and utilities. BlackRock Fund Advisors (BFA) serves as the investment advisor to the Fund.

Core S&P 500 iShares ETF

Vanguard 500 Index Fund (the Fund) is an open-end investment company, or mutual fund. The Fund offers four classes of shares: Investor Shares, Admiral Shares, Signal Shares, and Exchange Traded Fund (ETF) Shares. The Fund seeks to track the investment performance of the Standard & Poor’s 500 Index, an unmanaged benchmark representing the United States large-capitalization stocks. The Fund employs a passive management-or indexing-investment approach designed to track the performance of the Standard & Poor’s 500 Index. The Fund attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. 

S&P 500 Vanguard ETF

Tesla, Inc. designs, develops, manufactures, sells and leases fully electric vehicles and energy generation and storage systems, and offer services related to its products. The Company's automotive segment includes the design, development, manufacturing, sales, and leasing of electric vehicles as well as sales of automotive regulatory credits. Additionally, the automotive segment is also comprised of services and other, which includes non-warranty after-sales vehicle services, sales of used vehicles, retail merchandise, sales by its acquired subsidiaries to third party customers, and vehicle insurance. Its energy generation and storage segment include the design, manufacture, installation, sales and leasing of solar energy generation and energy storage products and related services and sales of solar energy systems incentives. Its automotive products include Model 3, Model Y, Model S and Model X. Powerwall and Megapack are its lithium-ion battery energy storage products.

Tesla, Inc.

Apple Inc. (Apple) designs, manufactures and markets smartphones, personal computers, tablets, wearables and accessories and sells a range of related services. The Company’s products include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, HomePod, iPod touch and accessories. The Company operates various platforms, including the App Store, which allows customers to discover and download applications and digital content, such as books, music, video, games and podcasts. Apple offers digital content through subscription-based services, including Apple Arcade, Apple Music, Apple News+, Apple TV+ and Apple Fitness+. Apple also offers a range of other services, such as AppleCare, iCloud, Apple Card and Apple Pay. Apple sells its products and resells third-party products in a range of markets, including directly to consumers, small and mid-sized businesses, and education, enterprise and government customers through its retail and online stores and its direct sales force.

Apple, Inc.

Microsoft Corporation is a technology company. The Company develops and supports software, services, devices, and solutions. Its segments include Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment consists of products and services in its portfolio of productivity, communication, and information services, spanning a variety of devices and platforms. This segment includes Office Consumer, LinkedIn, Dynamics business solutions, and Office Commercial. The Intelligent Cloud segment consists of its public, private, and hybrid server products and cloud services. This segment includes server products and cloud services, and enterprise services. The More Personal Computing segment consists of products and services, such as Windows, devices, gaming, and search and news advertising.

Microsoft Corporation

Vanguard Information Technology ETF seeks to track the investment performance of the MSCI US Investable Market Information Technology 25/50 Index, a benchmark of large-, mid-, and small-cap United States stocks in the information technology sector, as classified under the Global Industry Classification Standard (GICS). This GICS sector is made up of companies in three areas: technology software and services, including companies that develop software in various fields (such as the Internet, applications, systems, databases, and/or home entertainment), and companies that provide information technology consulting and services, data processing, and outsourced services; technology hardware and equipment, including manufacturers and distributors of communications equipment, computers and peripherals and electronic equipment, and semiconductors and semiconductor equipment manufacturers. The Vanguard Group, Inc. serves as advisor to the Fund through its Quantitative Equity Group.

	SRPT	IVV
Popularity	N/A	Low
Pearlers invested	0	59
Median incremental investment	$0	$0
Median investment frequency	N/A	N/A
Median total investment	$0	$0
Average age group	N/A	N/A

	SRPT	IVV
Strategy	N/A	N/A
Top 3 holdings		Apple, Inc. (7.40 %) Microsoft Corporation (7.02 %) Amazon.com Inc. (3.04 %)
Top 3 industries
Top 3 countries
Management fee	N/A	N/A

	SRPT	IVV
Issuer	N/A	N/A
Tracking index	N/A	N/A
Asset class	Stock	Stock
Management fee	N/A	N/A
Price	$126.82 USD	$421.95 USD
Size	N/A	N/A
10Y return	225.93 %	152.75 %
Annual dividend/ distribution yield (5Y)	- %	- %
Market	US	US
First listed date	N/A	N/A
Purchase fee	$6.50	$6.50

	SRPT	IVV
Popularity	N/A	Low
Pearlers invested	0	59
Median incremental investment	$0	$0
Median investment frequency	N/A	N/A
Median total investment	$0	$0
Average age group	N/A	N/A

	SRPT	IVV
Pros
Cons

Compare US

Compare SRPT vs. IVV

Overview

Performance

Industry & Region

Top Holdings

Overview

Community Stats

Key Summary

Key Summary

Community Stats

Pros and Cons